期刊文献+

噎膈证方对人表皮生长因子刺激的食管癌EC9706细胞生长信号转导的影响 被引量:15

Influence of Prescriptions for Esophageal Carcinoma on Growth Signal Transduction in hEGF-Stimulated Cell Line EC9706
原文传递
导出
摘要 目的:研究噎膈病辨证施方在不同浓度下对食管癌细胞生长的影响;从生长信号转导角度探讨启膈散等对人表皮生长因子(hEGF)刺激的食管癌EC9706细胞生长抑制机理。方法:体外培养人表皮生长因子(hEGF)刺激的EC9706食管鳞癌细胞株,分别加入启膈散等4方提取液,通过MTT染色、流式细胞技术等观察细胞增殖变化;以western blot法检测PLC-γ1介导的生长信号通路蛋白表达。结果:启膈散(Q)、沙参麦冬汤(S)、通幽汤(T)IC50值分别为849,1004,1 615μg.mL-1;可抑制PLC-γ1信号通路相关蛋白表达,抑制作用强度:T>Q>S;结论:除补气运脾汤外,噎膈证方可抑制hEGF刺激的EC9706细胞的生长;启膈散等3方可通过抑制PLC-γ1介导的生长信号转导而抑制EC9706细胞生长。 Objective:To discuss effects of prescriptions for esophageal carcinoma in different concentrations on the proliferation of esophageal carcinoma cell line EC9706 stimulated by hEGF;to discuss inhibition mechanism of the prescriptions on esophageal carcinoma EC9706 cells stimulated by hEGF from the view of growth signal transduction.Methods: Human esophageal carcinoma cell line EC9706 cultured in vitro treated with hEGF and Qigesan(Q),Shashenmaidongtang(S),Tongyoutang(T) and Buqiyunpitang(B),cells proliferation is assayed by MTT,cells proliferation and cells cycle are measured by FCM.Associated proteins within growth signal pathway mediated by PLC-γ1 were determined by western blot.Results: The half maximum inhibition rates(IC50) of Q,S and T are 849,(1 004),(1 615) μg·mL.These 3 prescrip tions could inhibit associated proteins expression within signal pathway mediated by PLC-γ1,the effects of T and Q were better than S.Conclusion: Q S and T could inhibit cells proliferation stimulated by hEGF.The inhibition of B is very weak.The prescriptions influence EC9706 cells proliferation by inhibiting proteins expression associated with growth signal pathway mediated by PLCγ1.
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第3期100-103,108,共5页 Chinese Journal of Experimental Traditional Medical Formulae
关键词 食管癌 人表皮生长因子 启膈散 沙参麦冬汤 通幽汤 补气运脾汤 esophageal carcinoma hEGF Qigesan Shashenmaidongtang Tongyoutang Buqiyunpitang
  • 相关文献

参考文献4

二级参考文献16

  • 1司富春,陈玉龙.古方治疗噎膈用药分析[J].山东中医杂志,2004,23(7):385-387. 被引量:15
  • 2那彦群,李鸣.重视前列腺癌诊治规范化研究[J].中华医学杂志,2005,85(45):3169-3169. 被引量:21
  • 3司富春 陈玉龙 李灿.中医药治疗食道癌方药分析[J].河南中医,2003,23:76-76. 被引量:1
  • 4司富春 陈玉龙 李灿.中医药治疗肿瘤药物分析[J].河南中医,2003,23:70-76. 被引量:1
  • 5Olson KB, Pienta KJ. The treatment of hormone refractory, prostate cancer. AUA Update Series, 1999.18 : 26-31. 被引量:1
  • 6Lonard DM, Smith CL. Molecular perspectives on selective estrogen receptor modulators (SERMs) : progress in understanding their tissue-specific agonist and antagonist actions. Steroid, 2002, 67: 15-24. 被引量:1
  • 7Kim IY, Kim BC, H Seong do, et al. Raloxifene, a mixed estrogen agonist/antagonist, induces apoptosis in androgen independent human prostate cancer cell lines. Cancer Res,2002, 62 : 5365-5369. 被引量:1
  • 8Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev, 2001, 81:807-869. 被引量:1
  • 9Mabuchi S, Ohmichi M, Kimura A, et al. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer ceil lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin. Endocrinology, 2004,145 : 1302-1313. 被引量:1
  • 10Lau KM, LaSpina M , long J, et al. Expression of estrogen receptor(ER)α and ER-β in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Cancer Res, 2000, 60: 3175-3182. 被引量:1

共引文献25

同被引文献195

引证文献15

二级引证文献119

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部